Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 26, 2022 at 07:46 am EDT
Share
Shenzhen Bioeasy Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 597.27 million compared to CNY 236.1 million a year ago. Revenue was CNY 597.54 million compared to CNY 258.46 million a year ago. Net income was CNY 236.51 million compared to CNY 65.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.6 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.6 compared to CNY 0.18 a year ago.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 
